CEL-SCI Closes $5 Million Public Offering-March 2024-www.financetom.com

CEL-SCI Closes $5 Million Public Offering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

CEL-SCI Closes $5 Million Public Offering

May 26, 2025 1:40 PM

04:34 PM EDT, 05/23/2025 (MT Newswires) -- CEL-SCI ( CVM ) said Friday it closed a $5 million underwritten public offering of shares.

The company sold 2 million shares at $2.50 each in the offering.

CEL-SCI ( CVM ) said it granted underwriters a 45-day option to buy up to an additional 190,000 shares to cover overallotments.

Net proceeds will be used for developing its investigational cancer treatment, Multikine, general corporate purposes, and working capital.

Previous page： Talos Energy Appoints Paul Goodfellow as CEO Next page： Tyson Foods raises annual sales forecast on beef and chicken demand

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Talos Energy Appoints Paul Goodfellow as CEO

Feb 3, 2025

07:32 AM EST, 02/03/2025 (MT Newswires) -- Talos Energy ( TALO ) said Monday it has appointed Paul Goodfellow as Chief Executive Officer and a member of its board, effective March 1. Before the appointment, Goodfellow served as executive vice president and group chief internal auditor at Shell (SHEL), overseeing the internal audit function. ...

Tyson Foods raises annual sales forecast on beef and chicken demand

Feb 3, 2025

Feb 3 (Reuters) - Tyson Foods ( TSN ) raised its annual sales forecast on Monday, after robust demand for its beef and chicken products helped the meat packer beat estimates for first-quarter results. The U.S. company expects fiscal 2025 sales to be flat to up 1%, compared with its prior forecast of flat to down 1%. Tyson also raised...

Twist Bioscience's Fiscal Q1 Loss Narrows, Revenue Rises; Fiscal 2025 Sales Guidance Lifted

Feb 3, 2025

07:33 AM EST, 02/03/2025 (MT Newswires) -- Twist Bioscience ( TWST ) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier. Analysts polled by FactSet expected a loss of $0.68. Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier. Analysts surveyed...

Market Chatter: Amazon, Other Online Platforms to Be Held Liable for Unsafe Products in EU

Feb 3, 2025

07:31 AM EST, 02/03/2025 (MT Newswires) -- Amazon.com ( AMZN ) , PDD Holdings ( PDD )-owned (PDD) Temu and other online shopping platforms will be held accountable in the EU for illegal or hazardous products sold online, the Financial Times reported Saturday, citing proposed customs reforms. Under the draft proposal, e-commerce platforms would be required to submit customs information...